Patents by Inventor Peter Michael Dierks

Peter Michael Dierks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6235278
    Abstract: Provided herein are genetically engineered baculoviruses which express insect-specific toxins, preferably paralytic neurotoxins, under the regulatory control of strong promoters expressed early after infection and in a wide variety of insect cells. Particularly preferred insect-specific paralytic neurotoxins are those of insect-predacious mites, including Pyemotes. The genetically engineered baculoviruses of the present invention are improved over prior art viruses in that they produce efficacious insect-toxic levels of the neurotoxin at earlier times after infection, particularly in comparison to baculoviruses in which the toxin is expressed under the control of a polyhedrin or granulin promoter. Insect-toxic compositions are also provided and methods of insect control using these compositions are described.
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: May 22, 2001
    Assignees: University of Georgia Research Foundation, Inc., American Cyanamid Co.,
    Inventors: Lois K. Miller, Albert Lu, Bruce Christian Black, Peter Michael Dierks
  • Patent number: 5662897
    Abstract: Insect viruses capable of killing at least one target insect pest quicker than previously described viruses and DNA sequence conferring that phenotype of faster killing are provided. Further improvement in the speed of killing is obtained when the virus of this invention also contains a nonfunctional egt gene to reduce feeding by the infected larvae, inhibit growth and further mediate the earlier death of the infected insect. A specifically exemplified faster-killing insect virus is the V-8 strain of AcMNPV. The faster killing phenotype is carried on a MluI to EspI fragment from 1.93 to 3.27 map units within the AcMNPV genome, and its sequence is provided herein as SEQ ID NO: 3 . . . V8vEGTDEL is the egt-inactivated derivative of AcMNPV V-8; the combination of the increased virulence of the V-8 genotype, for example, and the inactivation of the gene encoding ecdysteroid glycosyl transferase provides further improvement (as further decrease in time after infection until insect death).
    Type: Grant
    Filed: July 27, 1994
    Date of Patent: September 2, 1997
    Assignees: U. of GA Research Foundation, American Cyanamid Co.
    Inventors: Lois K. Miller, Bruce Christian Black, Peter Michael Dierks, Nancy C. Fleming